Silverlake Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
84,200
+8,263
| +11% | +$200K | 0.59% | 45 |
|
|
2025
Q1 | $1.92M | Sell |
75,937
-752
| -1% | -$19.1K | 0.73% | 40 |
|
|
2024
Q4 | $2.03M | Buy |
76,689
+5,966
| +8% | +$158K | 0.78% | 30 |
|
|
2024
Q3 | $2.05M | Buy |
70,723
+11,833
| +20% | +$342K | 0.78% | 28 |
|
|
2024
Q2 | $1.65M | Buy |
58,890
+6,042
| +11% | +$169K | 0.68% | 37 |
|
|
2024
Q1 | $1.47M | Buy |
52,848
+5,223
| +11% | +$145K | 0.75% | 31 |
|
|
2023
Q4 | $1.37M | Sell |
47,625
-1,604
| -3% | -$46.2K | 0.76% | 31 |
|
|
2023
Q3 | $1.63M | Sell |
49,229
-2,474
| -5% | -$82.1K | 0.92% | 23 |
|
|
2023
Q2 | $1.9M | Buy |
51,703
+944
| +2% | +$34.6K | 1.05% | 19 |
|
|
2023
Q1 | $2.07M | Sell |
50,759
-510
| -1% | -$20.8K | 1.26% | 15 |
|
|
2022
Q4 | $2.63M | Sell |
51,269
-887
| -2% | -$45.5K | 1.64% | 9 |
|
|
2022
Q3 | $2.28M | Sell |
52,156
-5
| -0% | -$219 | 1.55% | 9 |
|
|
2022
Q2 | $2.73M | Buy |
52,161
+1,592
| +3% | +$83.5K | 1.78% | 8 |
|
|
2022
Q1 | $2.62M | Sell |
50,569
-3,034
| -6% | -$157K | 1.5% | 8 |
|
|
2021
Q4 | $3.17M | Buy |
+53,603
| New | +$3.17M | 1.7% | 7 |
|